Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan · Delayed Price · Currency is TWD 23.85
-0.05 (-0.21%)
At close: Feb 6, 2026
Bioray Biotech Market Cap
Bioray Biotech has a market cap or net worth of 705.61 million as of February 6, 2026. Its market cap has increased by 20.98% in one year.
Market Cap
705.61M
Enterprise Value
602.05M
Revenue
230.06M
Ranking
n/a
PE Ratio
23.26
Stock Price
23.85
Market Cap Chart
Since July 6, 2020, Bioray Biotech's market cap has decreased from 1.94B to 705.61M, a decrease of -63.64%. That is a compound annual growth rate of -16.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 707.09M | 14.35% |
| Dec 31, 2025 | 618.33M | -2.69% |
| Dec 31, 2024 | 635.45M | -31.65% |
| Dec 29, 2023 | 929.63M | 3.17% |
| Dec 30, 2022 | 901.05M | -30.18% |
| Dec 30, 2021 | 1.29B | 56.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InnoPharmax | 1.75B |
| Tien Liang BioTech | 1.71B |
| Winston Medical Supply | 1.56B |
| DV Biomed | 1.43B |
| Excelsior Biopharma | 1.28B |
| Prince Pharmaceutical | 1.08B |
| Anxo Pharmaceutical | 1.06B |
| Mediera | 1.01B |